PubRank

Nagalakshmi Nadiminty

Author PubWeight™ 20.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lin28 promotes growth of prostate cancer cells and activates the androgen receptor. Am J Pathol 2013 1.53
2 Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clin Cancer Res 2009 1.32
3 Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression. Prostate 2007 1.23
4 Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem 2004 1.15
5 Functional p53 determines docetaxel sensitivity in prostate cancer cells. Prostate 2012 1.10
6 Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). Prostate 2006 1.07
7 Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer. Mol Cancer Ther 2013 1.03
8 Sanguinarine suppresses prostate tumor growth and inhibits survivin expression. Genes Cancer 2010 1.01
9 Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells. Prostate 2005 0.99
10 Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST). Prostate 2014 0.98
11 Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate 2011 0.97
12 Andrographolide targets androgen receptor pathway in castration-resistant prostate cancer. Genes Cancer 2011 0.96
13 Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer. Mol Cancer Ther 2006 0.93
14 Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Cancer Res 2005 0.87
15 RhoGDIα suppresses growth and survival of prostate cancer cells. Prostate 2011 0.86
16 Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells. Endocr Relat Cancer 2014 0.86
17 Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth. Genes Cancer 2010 0.83
18 Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Prostate 2007 0.82
19 Interleukin-4 activates androgen receptor through CBP/p300. Prostate 2009 0.81
20 RhoGDIα downregulates androgen receptor signaling in prostate cancer cells. Prostate 2013 0.80
21 Transcriptional regulation of human RANK ligand gene expression by E2F1. Biochem Biophys Res Commun 2008 0.76